KRAS Mutations and Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer With Lymph Node Metastases

被引：11
|
作者：
Velho, Sergia [1 ]
Oliveira, Carla [1 ,2 ]
Seruca, Raquel [1 ,2 ]
机构：
[1] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 01期
关键词：
CETUXIMAB; PANITUMUMAB; BRAF;
D O I：
10.1200/JCO.2008.20.1525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：158 / 159
页数：3
相关论文
共 50 条
  • [21] Cetuximab, A Chimeric Anti-Epidermal Growth Factor Receptor Monoclonal Antibody, in Colorectal Cancer Treatment
    Martinelli, Erika
    Orditura, Michele
    De Vita, Ferdinando
    Galizia, Gennaro
    Ciardiello, Fortunato
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 242 - 248
  • [22] Patterns of Use and Tolerance of Anti-Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer
    Dotan, Efrat
    Devarajan, Karthik
    D'Silva, A. James
    Beck, Andrew
    Kloth, Dwight D.
    Cohen, Steven J.
    Denlinger, Crystal
    CLINICAL COLORECTAL CANCER, 2014, 13 (03) : 192 - 198
  • [23] Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations
    Custodio, Ana
    Feliu, Jaime
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (01) : 45 - 81
  • [24] Magnesium monitoring practice in monoclonal anti-epidermal growth factor receptor antibodies therapy
    do Pazo-Oubina, F.
    Estefanell-Tejero, A.
    Riu-Viladoms, G.
    Anglada-Martinez, H.
    Molas-Ferrer, G.
    Creus-Baro, N.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 101 - 103
  • [25] PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
    Sood, Arjun
    McClain, Danielle
    Maitra, Radhashree
    Basu-Mallick, Atrayee
    Seetharam, Raviraja
    Kaubisch, Andreas
    Rajdev, Lakshmi
    Mariadason, John M.
    Tanaka, Kathryn
    Goel, Sanjay
    CLINICAL COLORECTAL CANCER, 2012, 11 (02) : 143 - 150
  • [26] American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
    Allegra, Carmen J.
    Jessup, J. Milburn
    Somerfield, Mark R.
    Hamilton, Stanley R.
    Hammond, Elizabeth H.
    Hayes, Daniel F.
    McAllister, Pamela K.
    Morton, Roscoe F.
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2091 - 2096
  • [27] Panitumumab, a monoclonal anti-epidermal growth factor receptor antibody in colorectal cancer: Another one or the one?
    Messersmith, Wells A.
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4664 - 4666
  • [28] Anti-epidermal growth factor receptor targeted therapy-associated ulcerations
    Thermos, Grigorios
    Kalogirou, Eleni-Marina
    Tosios, Konstantinos I.
    ORAL ONCOLOGY, 2024, 148
  • [29] Integration of Anti-Epidermal Growth Factor Receptor Therapies With Cytotoxic Chemotherapy
    Serrano, Cesar
    Markman, Ben
    Tabernero, Josep
    CANCER JOURNAL, 2010, 16 (03) : 226 - 234
  • [30] Systemic Therapy for Advanced or Metastatic Colorectal Cancer: National Comprehensive Cancer Network Guidelines for Combining Anti-Vascular Endothelial Growth Factor and Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Chemotherapy
    Engstrom, Paul F.
    PHARMACOTHERAPY, 2008, 28 (11): : 18S - 22S
12345